Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    NCT01245062
Show Display Options
Rank Status Study
1 Active, not recruiting
Has Results
GSK1120212 vs Chemotherapy in Advanced or Metastatic BRAF V600E/K Mutation-positive Melanoma
Condition: Melanoma
Interventions: Drug: GSK1120212;   Drug: Chemotherapy

Indicates status has not been verified in more than two years